Dosage and administration
Apply a small amount of Elmore Oil to the pain affected area and gently massage in until fully absorbed. Use before and after activity for maximum relief.
Apply a small amount of Elmore Oil to the pain affected area and gently massage in until fully absorbed. Use before and after activity for maximum relief.
Tea Tree Oil (Melaleuca Alternifolia) - 4.25% (42.5 mg/ml)
Eucalyptus Oil (Eucalyptus radiata ) - 3.86% (38.6 mg/ml)
Massage Oil to assist with relief of joint and muscle pain
Temporary relief of joint and muscle pain, including lower back pain
Apply a small amount of Elmore Oil to the pain affected area and gently massage in until fully absorbed. Use before and after activity for maximum relief.
For external use only.
Keep out of reach of children
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69594-002-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-270f-f424-e053-dadaa90a57ce | Elmore Oil |
| 69594-002-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-270f-f424-e053-dadaa90a57ce | Elmore Oil |
| 69594-002-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-270f-f424-e053-dadaa90a57ce | Elmore Oil |
| 69594-002-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-270f-f424-e053-dadaa90a57ce | Elmore Oil |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69594-002-01 | Elmore Oil | 50 mL in 1 BOTTLE | OIL | 50 | 2 | |
| 69594-002-02 | Elmore Oil | 125 mL in 1 BOTTLE | OIL | 125 | 2 | |
| 69594-002-03 | Elmore Oil | 250 mL in 1 BOTTLE | OIL | 250 | 2 | |
| 69594-002-04 | Elmore Oil | 300 mL in 1 BOTTLE | OIL | 300 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Eucalyptus Oil | ACTIVE INGREDIENT | 2R04ONI662 | 1 | |
| Tea Tree Oil | ACTIVE INGREDIENT | VIF565UC2G | 1 | |
| EUCALYPTUS OIL | ACTIVE MOIETY | 2R04ONI662 | 1 | |
| Tea Tree Oil | ACTIVE MOIETY | VIF565UC2G | 1 | |
| OLIVE OIL | INACTIVE INGREDIENT | 6UYK2W1W1E | 1 | |
| VANILLIN | INACTIVE INGREDIENT | CHI530446X | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69594-002 | 69594-002-01, 69594-002-02, 69594-002-03, 69594-002-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Eucalyptus Oil | 2R04ONI662 | ACTIB |
| Tea Tree Oil | VIF565UC2G | ACTIB |
| OLIVE OIL | 6UYK2W1W1E | IACT |
| VANILLIN | CHI530446X | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| VANILLIN | VANILLIN | CHI530446X | TABLET / ORAL | 12 mg | ||
| VANILLIN | VANILLIN | CHI530446X | SOLUTION / ORAL | 2.5 mg/5ml | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, CHEWABLE / ORAL | 2.5 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| VANILLIN | VANILLIN | CHI530446X | POWDER, FOR SUSPENSION / ORAL | 2 mg/1ml | ||
| VANILLIN | VANILLIN | CHI530446X | SUSPENSION / ORAL | 6 mg | ||
| VANILLIN | VANILLIN | CHI530446X | OINTMENT / TOPICAL | NA | ||
| OLIVE OIL | OLIVE OIL | 6UYK2W1W1E | SOAP / TOPICAL | NA | ||
| OLIVE OIL | OLIVE OIL | 6UYK2W1W1E | SOLUTION / ORAL | 425 mg/1ml | ||
| OLIVE OIL | OLIVE OIL | 6UYK2W1W1E | LOTION / TOPICAL | 32468 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, FILM COATED / ORAL | 5 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, ORALLY DISINTEGRATING / ORAL | 0.26 mg | ||
| OLIVE OIL | OLIVE OIL | 6UYK2W1W1E | SOLUTION / TOPICAL | 0.6 %w/w | ||
| VANILLIN | VANILLIN | CHI530446X | SYRUP / ORAL | NA | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, EXTENDED RELEASE / ORAL | 3.4 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, COATED / ORAL | 65.5 mg | ||
| VANILLIN | VANILLIN | CHI530446X | LIQUID / ORAL | NA | ||
| OLIVE OIL | OLIVE OIL | 6UYK2W1W1E | CAPSULE / ORAL | NA | ||
| VANILLIN | VANILLIN | CHI530446X | ELIXIR / ORAL | NA | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46ac3eda-81c1-49e8-82c1-d01c9b6a09c8 | b1b544d0-3a89-4c4c-8213-9549aeba8bbf | 2016-04-05 | Warnings | 46ac3eda-81c1-49e8-82c1-d01c9b6a09c8 b1b544d0-3a89-4c4c-8213-9549aeba8bbf |
Adverse event summaries are temporarily unavailable. Other product information remains available.